Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis
International Immunopharmacology · 2026-11 · 189 · 117355
DOI: 10.1016/j.intimp.2026.117355 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Jingxu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD8-Positive T-Lymphocytes, S100 Proteins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Fudan University.
Abstract (Originalsprache)
Immune evasion in hepatocellular carcinoma (HCC) represents a major biological barrier limiting the efficacy of immunotherapy, yet its molecular basis remains incompletely understood. Increasing evidence indicates that tumor metabolic reprogramming and ferroptosis-related signaling play critical roles in shaping an immunosuppressive tumor microenvironment (TME); however, the specific regulatory factors involved remain unclear. This study aims to systematically elucidate the functional role of S100 calcium-binding protein A10 (S100A10) in immune evasion in HCC, with a particular focus on the molecular mechanisms by which S100A10 regulates CD8+ T-cell exhaustion through arachidonic acid (AA) metabolism and ferroptosis, as well as its potential therapeutic implications. To this end, data from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) cohort are integrated to analyze the expression patterns of S100A10, its prognostic value, and its association with the immune microenvironment. S100A10 overexpression and knockout models are established in HCCLM3 and MHCC97L cell lines, and S100A10-mediated metabolic pathway reprogramming is characterized using transcriptomic profiling, untargeted metabolomics, and ferroptosis-related functional assays. In parallel, single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics are employed to delineate the cell-type specificity and spatial distribution of S100A10. Furthermore, human CD8+ T-cell co-culture systems and orthotopic mouse HCC models are used to evaluate the impact of S100A10 on immune function and responsiveness to anti-programmed cell death protein 1 (anti-PD-1) therapy. The results demonstrate that S100A10 is significantly upregulated in HCC and is closely associated with poor prognosis and an immunosuppressive state. Mechanistically, S100A10 activates cytosolic phospholipase A2-arachidonate 5-lipoxygenase (cPLA2-5-LOX)-mediated AA oxidative metabolism, leading to the accumulation of lipid peroxidation products and ferroptosis-associated signals, thereby driving CD8+ T-cell exhaustion and promoting immune evasion. Significantly, inhibition of S100A10 reshapes the tumor immune microenvironment (TIME) and enhances the therapeutic efficacy of anti-PD-1 treatment. Collectively, these findings identify S100A10 as a critical regulator of metabolic-immune coupling in HCC and provide a theoretical basis for combinatorial strategies targeting metabolism and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
- Department of Liver Surgery and Transplantation and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Rehabilitation Medicine, Pudong Hospital Affiliated to Fudan University, Shanghai 201399, China.
- Rehabilitation Medicine Department, Hebei General Hospital, Shijiazhuang 050000, Hebei, China. Electronic address: linzhoukj@163.com.
- Department of Hepatobiliary Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China. Electronic address: xiaoliangwang2023@163.com.
Förderung
- Fudan University
Zitieren
APA
Zhang, J., Wang, G., Zhou, Z., Pu, B., Zhang, X., Ji, X., & Wang, X. (2026). Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis. International Immunopharmacology, 189, 117355. https://doi.org/10.1016/j.intimp.2026.117355
Vancouver
Zhang J, Wang G, Zhou Z, Pu B, Zhang X, Ji X, et al. Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis. International Immunopharmacology. 2026;189:117355. doi:10.1016/j.intimp.2026.117355
BibTeX
@article{Zhang2026,
author = {Zhang, Jingxu and Wang, Ganggang and Zhou, Zhijie and Pu, Bingbing and Zhang, Xin and Ji, Xinyu and Wang, Xiaoliang},
title = {Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis},
journal = {International Immunopharmacology},
year = {2026},
volume = {189},
pages = {117355},
doi = {10.1016/j.intimp.2026.117355}
}
EUVIMED